State panel ends probe of use of ex­e­cu­tion drugs

The Washington Times Daily - - AMERICAN SCENE -

LIT­TLE ROCK | The Arkansas Med­i­cal Board on Thurs­day voted to end its in­ves­ti­ga­tion into how drugs used to ex­e­cute four in­mates in April were ob­tained af­ter the panel’s at­tor­ney said he found no ev­i­dence that any doc­tors li­censed by the state were in­volved.

Last month the board had said it was in­ves­ti­gat­ing the pur­chase of one of the drugs used in the state’s first ex­e­cu­tions in nearly 12 years.

But board at­tor­ney Kevin O’Dwyer said Thurs­day that he didn’t find any ev­i­dence of a vi­o­la­tion of the state’s med­i­cal prac­tices act by a li­censed doc­tor be­cause none was in­volved in ob­tain­ing the ex­e­cu­tion drug.

Doc­tors can par­tic­i­pate in ex­e­cu­tions un­der Arkansas law. But ques­tions were raised in a court case about whether Arkansas im­prop­erly used a doc­tor’s name and li­cense to pur­chase one of the drugs.

The De­part­ment of Cor­rec­tion has de­nied those claims.

Newspapers in English

Newspapers from USA

© PressReader. All rights reserved.